AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Lexaria Bioscience announced it raised $113,000 in an initial filing from an offering of $113,000
PUBLIC · LEXXSep 21, 2026•about 2 hours ago
Amount Raised
$113,000
Round Type
Pre-Seed
KelownaOtherBiotechnologyHealthcare
Company Information
Company
Lexaria Bioscience
Location
100 - 740 MCCURDY ROAD
Kelowna, British Columbia, Canada
About
Lexaria Bioscience Corp. is a global innovator in drug delivery platforms, focusing on improving the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. The company has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats, and operates a licensed in-house research laboratory. Additionally, the company holds a robust intellectual property portfolio with 39 patents granted and many patents pending worldwide.
Fundz sees it the moment Lexaria Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.